✦ LIBER ✦

Guillain–Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?

✍ Scribed by Quick, Silvio; Quick, Carmen; Schneider, Ralph; Sveric, Krunoslav; Katzke, Stefanie; Strasser, Ruth H.; Ibrahim, Karim

Book ID: 123605738
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 278 KB
Volume: 165
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2012.10.083

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma Exchange as a Therapy for Guillai

Plasma Exchange as a Therapy for Guillain-Barré Syndrome with Immune Complexes

✍ M. Valbonesi; S. Garelli; L. Mosconi; D. Zerbi; I. Celano 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Plasma Exchange as a Therapy for Guillai

Plasma Exchange as a Therapy for Guillain-Barré Syndrome with Immune Complexes

📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Risk factors for Guillain-Barré syndrome

Risk factors for Guillain-Barré syndrome: a population-based case-control study

✍ Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 36 KB

The acute phase reactant, fibrinogen, as

The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome

✍ Rashmi Sanjay; Janice Flanagan; Donata Sodano; Kenneth C. Gorson; Allan H. Roppe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The Guillian Barré syndrome is an acute inflammatory disorder for which plasma exchange is effective treatment. Up to 10% relapse after plasma exchange suggesting that treatment sometimes finishes before disease activity has resolved. We studied whether plasma fibrinogen, an inflammatory marker, mig